Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022

SELL
$29.88 - $37.04 $926 - $1,148
-31 Closed
0 $0
Q2 2018

Aug 09, 2018

SELL
$40.53 - $50.7 $810 - $1,014
-20 Reduced 39.22%
31 $1,000
Q4 2017

May 18, 2018

SELL
$50.3 - $64.39 $26,558 - $33,997
-528 Reduced 91.19%
51 $3,000
Q4 2017

Mar 07, 2018

BUY
$50.3 - $64.39 $29,123 - $37,281
579
579 $6,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.67B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.